3/27
10:42 pm
dgx
Whoop has LeBron – now it wants your mom [TechCrunch]
Neutral
Report
Whoop has LeBron – now it wants your mom [TechCrunch]
3/26
11:13 am
dgx
Healthee Introduces Cash-Pay Network to Help Employers Reduce Healthcare Costs by 20-50% [Yahoo! Finance]
Neutral
Report
Healthee Introduces Cash-Pay Network to Help Employers Reduce Healthcare Costs by 20-50% [Yahoo! Finance]
3/23
07:48 am
dgx
3 Mid-Cap Stocks with Warning Signs [Yahoo! Finance]
Low
Report
3 Mid-Cap Stocks with Warning Signs [Yahoo! Finance]
3/23
12:46 am
dgx
How Guardant's Shield Blood Test Rollout Through Quest Diagnostics (DGX) Has Changed Its Investment Story [Yahoo! Finance]
Low
Report
How Guardant's Shield Blood Test Rollout Through Quest Diagnostics (DGX) Has Changed Its Investment Story [Yahoo! Finance]
3/20
04:01 am
dgx
Global Diagnostic Labs Market to Grow at a CAGR of 6.66%, Reaching USD 223 Billion by 2032, Reports Vyansa Intelligence [Yahoo! Finance]
Low
Report
Global Diagnostic Labs Market to Grow at a CAGR of 6.66%, Reaching USD 223 Billion by 2032, Reports Vyansa Intelligence [Yahoo! Finance]
3/19
10:00 am
dgx
Quest Diagnostics to Release First Quarter Financial Results on April 21, 2026
Low
Report
Quest Diagnostics to Release First Quarter Financial Results on April 21, 2026
3/15
01:05 am
dgx
Low
Report
3/12
04:28 pm
dgx
Quest Diagnostics Elects Timothy Wentworth, Former CEO of Walgreens Boots Alliance, Evernorth Health Services and Express Scripts, to Board of Directors [Yahoo! Finance]
Low
Report
Quest Diagnostics Elects Timothy Wentworth, Former CEO of Walgreens Boots Alliance, Evernorth Health Services and Express Scripts, to Board of Directors [Yahoo! Finance]
3/12
04:07 pm
dgx
Quest Diagnostics Elects Timothy Wentworth, Former CEO of Walgreens Boots Alliance, Evernorth Health Services and Express Scripts, to Board of Directors
Low
Report
Quest Diagnostics Elects Timothy Wentworth, Former CEO of Walgreens Boots Alliance, Evernorth Health Services and Express Scripts, to Board of Directors
3/11
10:18 am
dgx
Quest Diagnostics Incorporated (DGX) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]
Low
Report
Quest Diagnostics Incorporated (DGX) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]
3/6
03:48 pm
dgx
Betterness Introduces the Agentic Health & Wellness MCP [Yahoo! Finance]
Low
Report
Betterness Introduces the Agentic Health & Wellness MCP [Yahoo! Finance]
3/2
09:29 am
dgx
Quest Diagnostics Introduces AI Companion to Help Patients Understand and Act on Lab Test Results [Yahoo! Finance]
Low
Report
Quest Diagnostics Introduces AI Companion to Help Patients Understand and Act on Lab Test Results [Yahoo! Finance]
3/2
09:02 am
dgx
Quest Diagnostics Introduces AI Companion to Help Patients Understand and Act on Lab Test Results
Low
Report
Quest Diagnostics Introduces AI Companion to Help Patients Understand and Act on Lab Test Results
2/28
07:38 am
dgx
A Look At Quest Diagnostics (DGX) Valuation After Recent Share Price Momentum [Yahoo! Finance]
Low
Report
A Look At Quest Diagnostics (DGX) Valuation After Recent Share Price Momentum [Yahoo! Finance]
2/26
08:36 am
dgx
Quest Diagnostics Names Benjamin Beauvalot Senior Vice President, Chief Strategy and M&A Officer [Yahoo! Finance]
Low
Report
Quest Diagnostics Names Benjamin Beauvalot Senior Vice President, Chief Strategy and M&A Officer [Yahoo! Finance]
2/26
08:24 am
dgx
Quest Diagnostics Names Benjamin Beauvalot Senior Vice President, Chief Strategy and M&A Officer
Low
Report
Quest Diagnostics Names Benjamin Beauvalot Senior Vice President, Chief Strategy and M&A Officer
2/25
10:20 am
dgx
Quest Diagnostics to Speak at the Leerink 2026 Global Healthcare Conference [Yahoo! Finance]
Low
Report
Quest Diagnostics to Speak at the Leerink 2026 Global Healthcare Conference [Yahoo! Finance]
2/25
10:00 am
dgx
Quest Diagnostics to Speak at the Leerink 2026 Global Healthcare Conference
Low
Report
Quest Diagnostics to Speak at the Leerink 2026 Global Healthcare Conference
2/22
02:02 am
dgx
Quest Diagnostics (NYSE:DGX) was downgraded by analysts at
Wall Street Ze
Low
Report
Quest Diagnostics (NYSE:DGX) was downgraded by analysts at
Wall Street Ze
2/12
08:43 am
dgx
Quest Diagnostics (NYSE:DGX) had its price target raised by analysts at Mizuho from $210.00 to $235.00. They now have an "outperform" rating on the stock.
Low
Report
Quest Diagnostics (NYSE:DGX) had its price target raised by analysts at Mizuho from $210.00 to $235.00. They now have an "outperform" rating on the stock.
2/11
10:13 am
dgx
Quest Diagnostics (NYSE:DGX) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Quest Diagnostics (NYSE:DGX) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
2/11
10:13 am
dgx
Quest Diagnostics (NYSE:DGX) was given a new $220.00 price target on by analysts at Evercore ISI.
Low
Report
Quest Diagnostics (NYSE:DGX) was given a new $220.00 price target on by analysts at Evercore ISI.
2/11
10:13 am
dgx
Quest Diagnostics (NYSE:DGX) was given a new $220.00 price target on by analysts at Truist Financial Corporation.
Low
Report
Quest Diagnostics (NYSE:DGX) was given a new $220.00 price target on by analysts at Truist Financial Corporation.
2/11
09:51 am
dgx
Quest Diagnostics (NYSE:DGX) had its price target raised by analysts at Barclays PLC from $210.00 to $225.00. They now have an "overweight" rating on the stock.
Low
Report
Quest Diagnostics (NYSE:DGX) had its price target raised by analysts at Barclays PLC from $210.00 to $225.00. They now have an "overweight" rating on the stock.
2/11
09:06 am
dgx
Quest Diagnostics (NYSE:DGX) was given a new $219.00 price target on by analysts at Robert W. Baird.
Low
Report
Quest Diagnostics (NYSE:DGX) was given a new $219.00 price target on by analysts at Robert W. Baird.